The hemostatic effect of progesterone administered vaginally at a dose
of 100 mg twice a day throughout one menstrual cycle was investigated
and compared with the coagulation factors in one untreated normal men
strual cycle in 15 women.; The progesterone treatment resulted in a 20
-fold progesterone rise in the early follicular phase from 1.2 nmol/l
in the pretreatment control cycle to levels between 26 and 29 nmol/l d
uring treatment. Ovulation was completely suppressed in seven women wh
ile eight women showed a slight rise in progesterone on treatment days
20 to 25 not compatible with the rise which could have been expected
if ovulation had occurred. The effects found on haemostasis during pro
gesterone treatment varied with the menstrual cycle and were so small
that they could as well be due to chance and not to treatment.